VAIA
HALO icon

Virtus Alternative Investment Advisers’s Halozyme HALO Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-211
Closed -$9K – 95
2020
Q4 		$9K Sell
211
-204
-49% -$7.33K 0.13% 54
2020
Q3 		$11K Sell
415
-217
-34% -$6.04K 0.2% 146
2020
Q2 		$17K Sell
632
-592
-48% -$13.4K 0.27% 88
2020
Q1 		$22K Buy
+1,224
New +$23.2K 0.3% 118

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtus Alternative Investment Advisers's HALO Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Halozyme (HALO) in Q1 2021, closing a stake of 211 shares — an estimated $9K sold.

Virtus Alternative Investment Advisers first reported a position in HALO in Q1 2020 and held it in 4 quarters. The position peaked at $22K in Q1 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 211 Halozyme shares in Q1 2021, an estimated $9K.
  • Virtus Alternative Investment Advisers first reported a position in Halozyme in Q1 2020 and held it in 4 quarters.
  • Virtus Alternative Investment Advisers's Halozyme position peaked at $22K in Q1 2020.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.